Synonyms: dideoxycytidine (DDC) | Hivid® | Ro-242027000/Ro-24-2027-000
zalcitabine is an approved drug (FDA (1992))
Compound class:
Synthetic organic
Comment: zalcitabine is a nucleoside analog reverse transcriptase inhibitor (NRTI) antiretroviral drug. Chemically it is an is an analogue of pyrimidine and is a derivative of endogenous deoxycytidine.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (1992)) |
IUPAC Name |
4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one |
International Nonproprietary Names | |
INN number | INN |
6871 | zalcitabine |
Synonyms |
dideoxycytidine (DDC) | Hivid® | Ro-242027000/Ro-24-2027-000 |
Database Links | |
CAS Registry No. | 7481-89-2 (source: Scifinder) |
ChEMBL Ligand | CHEMBL853 |
DrugBank Ligand | DB00943 |
DrugCentral Ligand | 2856 |
GtoPdb PubChem SID | 178101530 |
PubChem CID | 24066 |
Search Google for chemical match using the InChIKey | WREGKURFCTUGRC-POYBYMJQSA-N |
Search Google for chemicals with the same backbone | WREGKURFCTUGRC |
Search PubMed clinical trials | zalcitabine |
Search PubMed titles | zalcitabine |
Search PubMed titles/abstracts | zalcitabine |
UniChem Compound Search for chemical match using the InChIKey | WREGKURFCTUGRC-POYBYMJQSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | WREGKURFCTUGRC-POYBYMJQSA-N |
Wikipedia | Zalcitabine |